Dove’s Self-Esteem Project launches new campaign
ENGLEWOOD CLIFFS, N.J. — Unilever’s Dove has announced the launch of a new initiative, “Let’s Make Girls Unstoppable,” as part of its commitment to reach 15 million girls by 2015 with self-esteem programming.
The "Let’s Make Girls Unstoppable" effort launched May 3 at the fifth annual Mom 2.0 Summit to mom influencers with a special keynote conversation with journalist and writer Lisa Ling and Dove global self-esteem ambassador, Jess Weiner, who share the brand’s commitment to build self-esteem in girls everywhere. Together with Dove, they are encouraging moms and mentors to share photos, videos and stories of girls in their lives enjoying favorite activities to inspire girls across the country to keep going, to be confident and always be unstoppable.
These photos, videos and stories can be shared on:
- Twitter.com/Dove, using #GirlsUnstoppable
In the recent Real Beauty Sketches film, Dove explores how women are their own worst beauty critic.
"Dove knows that beauty anxiety and beauty pressure is felt by girls as young as eight years old," stated Rob Candelino, VP of Unilever Skincare. "We are giving women the tools and resources they need to start a conversation with the girl in their life, one of the most important women will ever have."
Inspiring the Next Generation
The Dove Self-Esteem Project, formerly known as the Dove Movement for Self-Esteem, educates young people to feel confident about their appearance and build their self-esteem. Dove has reached more than 11 million girls so far with self-esteem programming and, to continue helping women impact the next generation, they are unveiling new, free self-esteem education tools and activities specifically designed for moms, mentors and teachers. They are now available at Dove.com/girlsunstoppable.
Dove will continue its efforts to make girls unstoppable, hosting its fourth annual Dove Self-Esteem Weekend on Oct. 4 to 6 to celebrate unstoppable girls across the country with a series of self-esteem workshops, hosted by Dove and the brand’s national partner organizations (Girl Scouts of the US, The Boys & Girls Club of America and Girls, Inc.). Weiner will kick off the weekend with a special event in New York City.
It is laudable that Dove has a program to raise the self-esteem of young girls. Lack of self-esteem is one of the primary reasons for girls to fall victim to predators. So, it is more than a little puzzling that Dove would affiliate itself with two organizations that have partnered (at varying levels) with Planned Parenthood. Planned Parenthood promotes promiscuity (e.g. its porn site for teens); tells children to come to them for help and not to tell their parents; provides services to underage victims of vultures (as exposed by Lila Rose)without reporting to the proper authorities; make their money by providing birth control pills (a Group 1 carcinogen) and condoms (rated worst by Consumer Reports) and are the largest providers of abortions in the United States, (mostly targeting minorities as in the original plan of genocide by their founder Margaret Sanger). Real self-esteem comes from accomplishments. Early sexual forays are not an accomplishment. They are far more likely to send girls down the path of single teen motherhood, a direction that for the vast majority means lifelong poverty; academic and emotional problems for their children; and a drain on the local economy.
L’Oréal Paris teams up with Melanoma Research Alliance to battle melanoma
NEW YORK — In recognition of "Melanoma Monday," L’Oréal Paris has released a new survey on melanoma awareness and prevention among women of all skin tones, and announced a philanthropic alliance with the Melanoma Research Alliance.
Over the next three years, L’Oréal Paris will donate more than $750,000 to the MRA to fund the new L’Oréal Paris-MRA Team Science Award, led by cancer researcher Dr. Meenhard Herlyn, to research ways to help prevent, cure and treat melanoma, the fastest growing cancer in the world and the deadliest form of skin cancer.
L’Oréal Paris will help fund the melanoma research through sales of its line of SPF sun care products, Sublime Sun. Through Dec. 31, for every Sublime Sun product sold in the United States, L’Oréal Paris will donate $1 to the MRA for the L’Oréal Paris-MRA Team Science Award, up to $250,000. 100% of the donation will go toward the research.
Throughout Melanoma/Skin Cancer Awareness Month in May and into the summer, L’Oréal Paris will also help create awareness and education for women of all skin tones about melanoma prevention through its website, social media and spokesmodels. Today, fewer than one-quarter (22%) of American women would give themselves an “A” for healthy sun care habits, according to the survey commissioned by L’Oréal Paris and conducted by Kelton Global. And, while people of all skin tones are at risk for melanoma, only 21% of Hispanic women and 12% of African-American women give themselves an “A” when it comes to sun protection.
L’Oréal Paris is encouraging people to test their "Skin IQ" and learn about melanoma myths and facts by visiting lorealparisusa.com/sun. To get further involved in the donation, people can also make a pledge on Facebook and Twitter to protect their skin. For each pledge from May through July, the company will donate an additional $1 to the MRA, up to $10,000.
"The Melanoma Research Alliance is an incredible organization that has made significant strides in funding melanoma research and advancing treatment. We are very proud to partner with the MRA to help find a cure for melanoma and drive awareness around this disease," stated Karen Fondu, president of L’Oréal Paris. "Our hope is to help drastically reduce the growing incidence of melanoma in this country by educating women that sunscreen should be a part of their daily beauty routine, no matter your skin tone or where you live."
Survey Shows Women Are Not Taking Preventative Steps against Melanoma
In the L’Oréal Paris survey conducted by Kelton, while the majority of American women are aware of melanoma, more than half of women give themselves a "C" or lower when grading their healthy sun care habits. Hispanic and African American women, among whom the incidence of melanoma is growing, are even less likely to take steps to protect their skin.
"Sometimes Latinas like myself and other women of color have this false perception that we aren’t at risk for skin cancer, when in fact, the rate of melanoma is actually increasing for us and can be more deadly," added actress, philanthropist and L’Oréal Paris spokesperson Eva Longoria. "We all need to wear sunscreen daily, get our skin checked regularly and be aware of the signs."
Some of the key findings from the survey include:
- Women lack information about melanoma and want to know more;
- 95% percent of American women who have heard of melanoma know that it first affects the skin, but for many, the knowledge stops there;
- Of those women who know of melanoma, far fewer know that not reapplying sunscreen every two hours (54%) or having freckles or moles (54%) could put someone at a higher risk for the disease;
- Less than 3-in-10 (28%) American women believe it’s possible they could develop melanoma in their lifetimes; this belief is even lower among African-American (7%) and Hispanic (16%) women; and
- While fewer than 3-in-10 (28%) American women who are aware of the disease believe they have a chance of developing it, 23% stress that they would like to know more about it.
Women know they should wear sunscreen, but don’t.
- Lack of sunscreen use is likely why many American women give themselves failing sun care grades. One-third (33%) of those who think they would earn a “C” or worse admit they rarely, if ever, wear sunscreen, versus 7& of those who would grade themselves better;
- 21% of U.S .women, 17% of Hispanic women and 37% of African-American women never or rarely wear sunscreen;
- Almost half (46% of U.S. women, 46% of Hispanic women and 36% of African-American women polled) only wear sunscreen when they know they’ll be in the sun for a long time; and
- Less than 1-in-10 (9%) American women wear sunscreen daily and reapply it every few hours.
- An alarming percentage of American women don’t take steps to check their skin for melanoma
- A minority (30% of American women, 15% of Hispanics and 19% African Americans) regularly give themselves skin exams;
- 86% of U.S. women would not recognize a melanoma on themselves;
- Only 11% of American women regularly see a dermatologist; and
- 88% of U.S. women, 89% of Hispanic women and 96% of African-American women have not had any kind of dialogue with a doctor about melanoma.
L’Oréal Paris -MRA Team Science Award to Fund Research on Melanoma Drivers
The L’Oréal Paris MRA Team Award will be awarded to researchers from the Wistar Institute and University of Pennsylvania in the United States, Oslo University Hospital in Norway and Leeds University in the United Kingdom. The research will be led by Meenhard Herlyn D.V.M., D.Sc. from the Wistar Institute, whose laboratory focuses on the biology that underlies melanoma.
The team of researchers will take an in-depth look into the drivers of melanoma susceptibility, development and progression to help lead to prevention and therapy for the disease. People with genetically determined phenotypes such as light skin color, which tans poorly, red hair, blue eyes or many moles are generally considered more susceptible to melanoma compared to those with none of these attributes. However, the fact that only a few of these individuals contract the disease suggests that environmental traits may also play a major role in susceptibility.
The expectation from the studies is the identification of co-drivers that cooperate with driver genes, which will, in the future, be the targets for melanoma prevention and therapy.
L’Oréal, which has a long history of sun protection, has developed for 2013 two new sunscreen forms of its L’Oréal Paris Sublime Sun collection. Now there’s high SPF oils and foaming mousse sunscreens, as well as expanded SPF offerings for the pre-existing Sublime Sun line. The full L’Oréal Paris Sublime Sun Collection is comprised of 12 products for face and body.
No comments found
Swiss Precision Diagnostics showcases latest in home pregnancy test technology at OBGYN meeting
NEW ORLEANS — Swiss Precision Diagnostics on Monday unveiled the new Clearblue Advanced Pregnancy Test with Weeks Estimator at the 61st Annual Clinical Meeting of the American Congress of Obstetricians and Gynecologists here. The latest home pregnancy test kit not only tells a woman if she is pregnant but also estimates the number of weeks since ovulation.
“Confirming pregnancy is a life-changing moment in any woman’s life, and it sparks so many immediate questions like when did I get pregnant? That’s why we are thrilled to be able to bring the new Clearblue Advanced Pregnancy Test with Weeks Estimator to women in the United States,” stated Kirsten Suarez, Clearblue brand manager. “This test was created based on years of qualitative and quantitative consumer research and a clear understanding that a woman wants as much information as possible as soon as she receives a positive result. The Clearblue Advanced Pregnancy Test with Weeks Estimator gives her more information right at the beginning of this new phase in her pregnancy journey than she’s ever had before.”
Currently, the majority of physicians estimate weeks of pregnancy using a formula based on a woman’s last menstrual period. However, one in six women do not have a last menstrual period recorded and approximately 70% are uncertain of their last menstrual period.
The Clearblue Advanced Pregnancy Test with Weeks Estimator uses technology that takes two measurements instead of one and not only gives an accurate pregnancy result but also estimates the number of weeks since ovulation. The test is more than 99% accurate in detecting pregnancy from the day of the expected period, and it is approximately 93% accurate in estimating how many weeks based on time since ovulation.
All home pregnancy tests are designed to detect the hormone hCG in urine to determine pregnancy. However, the Clearblue Advanced Pregnancy Test with Weeks Estimator also measures the concentration of hCG, which helps estimate when fertilization occurred. If the test is positive, ‘Pregnant’ will be clearly indicated in words on the display along with an estimate of how many weeks have occurred since ovulation: 1-2 weeks, 2-3 weeks or 3+ weeks.
The Clearblue Advanced Pregnancy Test with Weeks Estimator will be available in stores and online in September 2013, the company noted.
Are you a nurse practitioner or physician’s assistant? Join our Facebook group to get all the latest news dedicated to delivering healthcare services to patients in retail pharmacy clinics.
No comments found